Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.

Kamper P, Bendix K, Hamilton-Dutoit S, Honoré B, Nyengaard JR, d'Amore F.

Haematologica. 2011 Feb;96(2):269-76. doi: 10.3324/haematol.2010.031542. Epub 2010 Nov 11.

2.

Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.

Azambuja D, Natkunam Y, Biasoli I, Lossos IS, Anderson MW, Morais JC, Spector N.

Ann Oncol. 2012 Mar;23(3):736-42. doi: 10.1093/annonc/mdr157. Epub 2011 May 20.

3.

Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.

Krugmann J, Tzankov A, Gschwendtner A, Fischhofer M, Greil R, Fend F, Dirnhofer S.

Mod Pathol. 2003 Jun;16(6):566-73.

4.

CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma.

Klein JL, Nguyen TT, Bien-Willner GA, Chen L, Foyil KV, Bartlett NL, Duncavage EJ, Hassan A, Frater JL, Kreisel F.

Am J Clin Pathol. 2014 Mar;141(3):381-7. doi: 10.1309/AJCP61TLMXLSLJYS.

PMID:
24515766
5.

Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact.

Barros MH, Hassan R, Niedobitek G.

Clin Cancer Res. 2012 Jul 15;18(14):3762-71. doi: 10.1158/1078-0432.CCR-12-0129. Epub 2012 May 29.

6.

CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma.

Harris JA, Jain S, Ren Q, Zarineh A, Liu C, Ibrahim S.

Diagn Pathol. 2012 Jan 30;7:12. doi: 10.1186/1746-1596-7-12.

7.

Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.

Diepstra A, van Imhoff GW, Schaapveld M, Karim-Kos H, van den Berg A, Vellenga E, Poppema S.

J Clin Oncol. 2009 Aug 10;27(23):3815-21. doi: 10.1200/JCO.2008.20.5138. Epub 2009 May 26.

PMID:
19470931
8.

Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma.

Sánchez-Espiridión B, Martin-Moreno AM, Montalbán C, Medeiros LJ, Vega F, Younes A, Piris MA, Garcia JF.

Haematologica. 2012 Jul;97(7):1080-4. doi: 10.3324/haematol.2011.055459. Epub 2012 Feb 7.

9.

Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.

Keegan TH, Glaser SL, Clarke CA, Gulley ML, Craig FE, Digiuseppe JA, Dorfman RF, Mann RB, Ambinder RF.

J Clin Oncol. 2005 Oct 20;23(30):7604-13. Epub 2005 Sep 26. Review.

PMID:
16186595
10.

High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma.

Pedersen MB, Danielsen AV, Hamilton-Dutoit SJ, Bendix K, Nørgaard P, Møller MB, Steiniche T, d'Amore F.

Histopathology. 2014 Oct;65(4):490-500. doi: 10.1111/his.12407. Epub 2014 Apr 16.

PMID:
24592992
11.

Prognostic significance of macrophage infiltration in leiomyosarcomas.

Lee CH, Espinosa I, Vrijaldenhoven S, Subramanian S, Montgomery KD, Zhu S, Marinelli RJ, Peterse JL, Poulin N, Nielsen TO, West RB, Gilks CB, van de Rijn M.

Clin Cancer Res. 2008 Mar 1;14(5):1423-30. doi: 10.1158/1078-0432.CCR-07-1712.

12.

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial.

Tan KL, Scott DW, Hong F, Kahl BS, Fisher RI, Bartlett NL, Advani RH, Buckstein R, Rimsza LM, Connors JM, Steidl C, Gordon LI, Horning SJ, Gascoyne RD.

Blood. 2012 Oct 18;120(16):3280-7. doi: 10.1182/blood-2012-04-421057. Epub 2012 Sep 4.

13.

The prognostic role of tumor-associated macrophages and dendritic cells in classic Hodgkin's lymphoma.

Abdou AG, Asaad NY, Loay I, Shabaan M, Badr N.

J Environ Pathol Toxicol Oncol. 2013;32(4):289-305.

PMID:
24579783
14.

Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.

Koh YW, Yoon DH, Suh C, Huh J.

Ann Hematol. 2012 Sep;91(9):1403-12. doi: 10.1007/s00277-012-1464-8. Epub 2012 Apr 18.

PMID:
22526365
15.

The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages.

Koh YW, Kang HJ, Park C, Yoon DH, Kim S, Suh C, Go H, Kim JE, Kim CW, Huh J.

Oncologist. 2012;17(6):871-80. doi: 10.1634/theoncologist.2012-0034. Epub 2012 May 15.

16.

The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.

Medrek C, Pontén F, Jirström K, Leandersson K.

BMC Cancer. 2012 Jul 23;12:306. doi: 10.1186/1471-2407-12-306.

17.

[Clinical characteristics and prognosis analysis of patients with LMP-1 positive Hodgkin's lymphoma after EBV infection].

Ping LY, Ding N, Shi YF, Sun L, Zheng W, Xie Y, Wang XP, Tu MF, Lin NJ, Ying ZT, Liu WP, Deng LJ, Zhan C, Tian L, Feng LX, Song YQ, Zhu J.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Feb;22(1):78-84. doi: 10.7534/j.issn.1009-2137.2014.01.017. Chinese.

PMID:
24598656
18.

High efficacy of combined rituximab and gemcitabine on Epstein-Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice.

Decaudin D, Marszak FB, Couturier J, Mathiot C, Martin A, Némati F, Lantz O, Santo Jd, Arnaud P, Bordier V, Vincent-Salomon A, Poupon MF.

Anticancer Drugs. 2006 Jul;17(6):685-95.

PMID:
16917214
19.

Impact of Epstein-Barr virus in the clinical evolution of patients with classical Hodgkin's lymphoma in Brazil.

Souza EM, Baiocchi OC, Zanichelli MA, Alves AC, Assis MG, Eiras DP, Dobo C, Oliveira JS.

Hematol Oncol. 2010 Sep;28(3):137-41. doi: 10.1002/hon.933.

PMID:
20128016
20.

Supplemental Content

Support Center